BARCELONA – Brachytherapy with or without external beam radiation improved survival in patients with early-stage, inoperable endometrial cancer. Thatâ€™s according to findings of a population-based analysis that looked at data from the National Cancer Instituteâ€™s Surveillance, Epidemiology and End Resultsâ€”SEER database. Oncology Times reporter Sarah Maxwell spoke to author Sahaja Acharya MD, resident physician at Washington University in Saint Louis, who won the ESTRO 2015 Best Junior Presentation Award for the study announced to the Barcelona meeting.
You may also like...
Building Health For All Capacity In Tanzania 30 Mar, 2012 COVID-19 Co-Morbidity Risks Quantified from Three Continents Survey 28 May, 2020 Time from nephrectomy to metastasis confirmed as prognostic in patients with renal cell carcinoma treated with targeted therapies 13 Feb, 2014 ESTRO 2015 Round-up with President Philip Poortmans 3 May, 2015
- Previous story IGNITE Study: More Asians than Russians with Mutant EGFR Lung Adenocarcinoma; Adjuvant Erlotinib for Stage IIIA-N2 Disease
- Next story Low Dose Rate Prostate Brachytherapy Doubled Cancer-Free Survival: ASCENDE-RT Study Finding
- COVID-19 Co-Morbidity Risks Quantified from Three Continents SurveyMay 28, 2020
- Ultrahypofractionated Radiation Just As Effective for Prostate CancerMay 16, 2018
- First evidence that genome editing made patients with AIDS more resistant to HIVMarch 8, 2014
- Anticoagulation with warfarin can be beneficial in patients with atrial fibrillation and chronic kidney disease.March 7, 2014
- Prostate cancer: Adult exposure to bisphenol-A linked to prostate cancer riskMarch 6, 2014